2026 has been the year of commercialisation for Rhythm Biosciences (ASX:RHY). It has been the year that ColoSTAT has finally hit the market and while GeneType was already commercialised, it has similarly seen a pickup in momentum. ColoSTAT: Rolling out in the market and its proving to be a hit ColoSTAT was commercialised as a […]